SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-286931
Filing Date
2020-11-05
Accepted
2020-11-05 16:51:28
Documents
88
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d945763d10q.htm   iXBRL 10-Q 1676247
2 EX-31.1 d945763dex311.htm EX-31.1 10657
3 EX-31.2 d945763dex312.htm EX-31.2 10685
4 EX-32.1 d945763dex321.htm EX-32.1 6592
  Complete submission text file 0001193125-20-286931.txt   8091088

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rgen-20200930.xsd EX-101.SCH 52347
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgen-20200930_cal.xml EX-101.CAL 54881
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgen-20200930_def.xml EX-101.DEF 492321
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgen-20200930_lab.xml EX-101.LAB 519909
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgen-20200930_pre.xml EX-101.PRE 531773
10 EXTRACTED XBRL INSTANCE DOCUMENT d945763d10q_htm.xml XML 1339690
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 201291285
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences